Document Classification

Section Type: RESULTS

Text: The point estimates (90 % confidence intervals) for AUC0-t, AUC0 - yen and Cmax were 1. 0293 (0. 9476 - 1. 1178), 1. 0253 (0. 9185 - 1. 1443) and 1. 0425 (0. 9986 - 1. 0883) for gliclazide, and 0. 9887 (0. 9137 - 1. 0697), 0. 9915 (0. 9189 - 1. 0697) and 0. 9882 (0. 9295 - 1. 0505) for metformin, respectively, satisfying the bioequivalence criteria of 80 - 125 % as proposed by the US FDA and the Korean legislation.